TISSIUM

Paris, France

TISSIUM develops biodegradable sealants and adhesives for wound closure in the field of minimally-invasive surgery.

Jun 2026

Series D

Top Investors

European Investment BankBpifranceCathay CapitalBNP ParibasSofinnova Partners

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are TISSIUM's investors?

TISSIUM's investors include European Investment Bank, Bpifrance, Cathay Capital, BNP Paribas, Sofinnova Partners.

Where is TISSIUM headquartered?

TISSIUM is headquartered in Paris, France.

What does TISSIUM do?

TISSIUM develops biodegradable sealants and adhesives for wound closure in the field of minimally-invasive surgery.

What stage is TISSIUM at?

TISSIUM is at the Series D stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 24, 2026.

MLA

"TISSIUM — Funding & Investors." VCBacked, June 24, 2026, https://www.vcbacked.co/company/tissium. Accessed June 30, 2026.

APA

VCBacked. (2026). TISSIUM — Funding & Investors. Retrieved June 30, 2026, from https://www.vcbacked.co/company/tissium

Wikipedia (cite web)

{{cite web |title=TISSIUM — Funding & Investors |url=https://www.vcbacked.co/company/tissium |website=VCBacked |access-date=June 30, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 24, 2026.